Skip to main content
Opens in new window
NHS Wales
NHS 111 Wales
Skip Navigation
Accessibility
Contact us
Cymraeg
Cymraeg
All...
Search
All Wales Therapeutics and Toxicology Centre
Search
Cymraeg
Cymraeg
Menu
Home
Accessing medicines
Show Submenu For Accessing medicines
Medicine recommendations
Access to medicines in Wales
Make a submission
Medicines optimisation and safety
Show Submenu For Medicines optimisation and safety
Medicines optimisation guidance, resources and data
Yellow Card Centre Wales
Welsh National Poisons Unit
Sodium valproate information hub
Work in progress
News, meetings and events
Show Submenu For News, meetings and events
News
Meetings
Events
About us
Show Submenu For About us
Who we are
What we do
Our committees
Who we work with
Our research
Our reports and strategies
Sustainability
Contact us
More
×
NHS Wales
NHS 111 Wales
Accessibility
Contact us
All...
Search
Listen
Home
›
Files
›
SOAs
SOAs
21/02/2020
Statement of Advice (SOA): idarubicin hydrochloride (Zavedos) 2607
21/02/2020
Statement of Advice (SOA): idelalisib (Zydelig) 2375
21/02/2020
Statement of Advice (SOA): imatinib (Glivec) 2014
21/02/2020
Statement of Advice (SOA): infliximab (Remicade) 1067
21/02/2020
Statement of Advice (SOA): insulin degludec insulin aspart (Ryzodeg) 838
21/02/2020
Statement of Advice (SOA): ivabradine (Procoralan) 529
21/02/2020
Statement of Advice (SOA): nomegestrol acetate estradiol (Zoely) 1050
21/02/2020
Statement of Advice (SOA): nilotinib (Tasigna) 3615
21/02/2020
Statement of Advice (SOA): ketoconazole (Ketoconazole HRA) 2743
21/02/2020
Statement of Advice (SOA): ketorolac phenylephrine (Omidria) 1194
21/02/2020
Statement of Advice (SOA): lapatinib (Tyverb) 1649
21/02/2020
Statement of Advice (SOA): latanoprost (Xalatan) 1179
21/02/2020
Statement of Advice (SOA): ledispavir sofosbuvir (Harvoni) 3556
21/02/2020
Statement of Advice (SOA): lenalidomide (Revlimid) 4171
21/02/2020
Statement of Advice (SOA): lenalidomide (Revlimid) 1585
21/02/2020
Statement of Advice (SOA): natalizumab (Tysabri) 2225
21/02/2020
Statement of Advice (SOA): lidocaine prilocaine (Tempe) 1846
21/02/2020
Statement of Advice (SOA): liraglutide (Victoza) 3168
21/02/2020
Statement of Advice (SOA): liraglutide (Victoza) 1395
21/02/2020
Statement of Advice (SOA): lomitapide (Lojuxta) 1182
7
8
9
10
11
12
13
14
15
16
17
Follow AWTTC: